MedTrace Logo

An Observational Clinical Feasibility Study of the Magnetic Esophageal Sphincter

NCT01058070 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2021-02-01

Study results available
· View outcomes & findings →

Summary

Magnetic Esophageal Sphincter implant is intended to reinforce Esophageal Sphincter function in the treatment of Gastroesophageal Reflux Disease (GERD)

Conditions

  • Gastroesophageal Reflux Disease

Interventions

DEVICE

Torax Medical, Inc. LINX Reflux Management System

Implantable device, Magnetic Esophageal Sphincter

Sponsors & Collaborators

  • Torax Medical Incorporated

    lead INDUSTRY

Principal Investigators

  • Robert Ganz, MD · Minnesota Gastroenterolgy, PA

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-02-28
Primary Completion
2009-07-31
Completion
2013-08-31

Countries

  • United States
  • Italy
  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01058070 on ClinicalTrials.gov